Yahoo
NZSE - Delayed Quote NZD

Ryman Healthcare Limited (RYM.NZ)

1.7700 +0.0300 (+1.72%)
At close: October 30 at 5:00:03 PM GMT+13
Chart Range Bar
Loading chart for RYM.NZ
  • Previous Close 1.7400
  • Open 1.7500
  • Bid 1.7650 x --
  • Ask 1.7750 x --
  • Day's Range 1.7400 - 1.7800
  • 52 Week Range 1.6600 - 3.0500
  • Volume 808,461
  • Avg. Volume 1,844,850
  • Market Cap (intraday) 1.798B
  • Beta (5Y Monthly) 0.37
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5900
  • Earnings Date Nov 25, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date Dec 8, 2022
  • 1y Target Est 2.91

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the older people in New Zealand and Australia. The company's villages provide apartments and townhouses, and assisted-living in serviced apartments, and care center, which offers rest homes, hospitals, specialist dementia care, and respite care services. Ryman Healthcare Limited was founded in 1984 and is based in Christchurch, New Zealand.

www.rymanhealthcare.co.nz

--

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50) .

YTD Return

RYM.NZ
39.18%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
1.83%

1-Year Return

RYM.NZ
38.33%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
1.84%

3-Year Return

RYM.NZ
68.84%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
28.25%

5-Year Return

RYM.NZ
86.58%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
5.32%

Analyst Insights

View More

Analyst Price Targets

2.56
2.91 Average
1.7700 Current
3.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -20.05%

  • Return on Assets (ttm)

    0.20%

  • Return on Equity (ttm)

    -4.15%

  • Revenue (ttm)

    854.47M

  • Net Income Avi to Common (ttm)

    -171.34M

  • Diluted EPS (ttm)

    -0.5900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    20.29M

  • Total Debt/Equity (mrq)

    39.20%

  • Levered Free Cash Flow (ttm)

    352.43M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: